I-Mab Announces Participation at Jefferies and Piper Conferences in November

Rhea-AI Summary

I-Mab, a global biotechnology company, will be participating in two conferences in November 2023: the Jefferies London Healthcare Conference and the Piper Sandler 35th Annual Healthcare Conference. The company's CEO, Dr. Raj Kannan, and CMO, Dr. John Hayslip, will be presenting at both conferences. The conferences will provide opportunities for one-on-one and small group meetings with management. The webcast of the Jefferies conference will be available on I-Mab's IR website.

ROCKVILLE, Md. and SHANGHAI, China, Nov. 6, 2023 /PRNewswire/ -- I-Mab (Nasdaq: IMAB) (the "Company"), a global biotechnology company focused on bringing highly differentiated medicines to patients around the world through the discovery, development, and commercialization of novel immunotherapies and biologics, today announced its in-person participation in two conferences in November 2023, the Jefferies London Healthcare Conference and the Piper Sandler 35^th Annual Healthcare Conference. Details of the conferences and management presentation are as follows:

Jefferies London Healthcare Conference (In Person)

Presentation Time	Tuesday, November 14th at 10:30 a.m. GMT (5:30 a.m. EST)
Presenters	Mr. Raj Kannan, CEO Dr. John Hayslip, CMO
Webcast link	https://wsw.com/webcast/jeff287/imab/1828028 The webcast will also be available under "Event Calendar" on I-Mab's IR website at http://ir.i-mabbiopharma.com/
Meetings	One-on-one and small group meetings: Nov 14 – 16, 2023
Management Participants	Mr. Raj Kannan, CEO Dr. John Hayslip, CMO Mr. Tyler Ehler, Senior Director, Investor Relations

For more information, please contact your Jefferies representative.

Piper Sandler 35^th Annual Healthcare Conference (In Person)

Presentation Time	Thursday, November 30th at 8:30 a.m. EST
Presenters	Mr. Raj Kannan, CEO Dr. John Hayslip, CMO
Meetings	One-on-one and small group meetings: Nov 28 – 30, 2023
Management Participants	Mr. Raj Kannan, CEO Dr. John Hayslip, CMO Mr. Tyler Ehler, Senior Director, Investor Relations

For more information, please contact your Piper Sandler representative.

About I-Mab

I-Mab (Nasdaq: IMAB) is a global biotechnology company focused on bringing highly differentiated medicines to patients around the world through the discovery, development, and commercialization of novel immunotherapies and biologics. I-Mab's innovative pipeline is driven by internal R&D's Fast-to-Proof-of-Concept, Fast-to-Market development strategies, and through global partnerships. For more information, please visit https://www.i-mabbiopharma.com and follow us on LinkedIn, X, formerly known as Twitter, and WeChat.

I-Mab Contacts

Investors	Media
Tyler Ehler	Gigi Feng
Senior Director, Investor Relations	Chief Communications Officer
IR@i-mabbiopharma.com	PR@i-mabbiopharma.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/i-mab-announces-participation-at-jefferies-and-piper-conferences-in-november-301978319.html

SOURCE I-Mab

FAQ

What conferences is I-Mab participating in November 2023?

I-Mab is participating in the Jefferies London Healthcare Conference and the Piper Sandler 35th Annual Healthcare Conference.

Who will be presenting at the conferences?

Dr. Raj Kannan, CEO, and Dr. John Hayslip, CMO, will be presenting at both conferences.

Will there be opportunities for meetings with management?

Yes, there will be one-on-one and small group meetings with management at both conferences.

Where can I find the webcast of the Jefferies conference?

The webcast of the Jefferies conference will be available on I-Mab's IR website.

How can I get more information?

For more information, please contact your Jefferies representative for the Jefferies conference, and your Piper Sandler representative for the Piper Sandler conference.